Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China
/PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that...
Source: prnewswire.com